Merck, Moderna detail potential skin cancer vaccine progress


              FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022,  after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study. (AP Photo/Seth Wenig, File)
            
              FILE - A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020.  Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022,  after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study. (AP Photo/Bill Sikes, File)
Merck, Moderna detail potential skin cancer vaccine progress